Sentences with phrase «executive of cancer research»

Health campaigners have welcomed the ban, with professor Alex Markham, chief executive of Cancer Research UK saying: «Today's announcement kicks off the final countdown to a healthier England and to thousands of lives saved.»

Not exact matches

Recently, however, Barry Zekelman, the CEO and executive chairman of Zekelman Industries, also dabbled in biotech, co-financing a Boston cancer research startup called CureMeta.

Canaan Executive in Residence Anil Singhal takes stock of what he saw and heard at the annual American Association of Cancer Research meeting.

SOUTH SAN FRANCISCO, Calif. — February 5, 2018 — FLX Bio, Inc., a biopharmaceutical company focused on the discovery and development of oral small molecule drugs to activate the immune system against cancer, today announced the appointment of senior pharmaceutical research and development executive Michael F. Giordano, M.D., to its Board of Directors.

Participants included CEOs Jonathan Bush of Athenahealth, Ron Gutman of HealthTap, Dr. Clifford Hudis of the American Society of Clinical Oncology, Dr. Vivian Lee of University of Utah Health Care, VitalConnect CEO Nersi Nazari, James Park of Fitbit, and Andrew Witty of GSK, as well as President of Flex Health Solutions John Carlson, Multiple Myeloma Research Foundation Founder Kathy Giusti, Dr. Sanjay Gupta, Arianna Huffington, Andreessen Horowitz General Partner Vijay Pande, Parker Foundation President Sean Parker, Women's Alzheimer's Movement Founder Maria Shriver, and White House Cancer Moonshot Task Force Executive Director Greg Simon.

The executive director of policy at Cancer Research UK reveals how research underpins all progress made in the battle against Cancer Research UK reveals how research underpins all progress made in the battle againsResearch UK reveals how research underpins all progress made in the battle againsresearch underpins all progress made in the battle against cancercancer

Science and Technology — Subject: Clinical trials Witness (es): Professor Karol Sikora, Medical Director of Cancer Partners UK and Dean, University of Buckingham Medical School and Simon Denegri, NIHR National Director for Public Participation and Engagement in Research and Chair, INVOLVE; Tracey Brown, Managing Director, Sense About Science and Dr Helen Jamison, Deputy Director, Science Media Centre; Sir Kent Woods, Chief Executive,, Dr Janet Wisely, Chief Executive, Health Research Authority, Bill Davidson, Acting Deputy Director and Head of Research Standards and Support, Department of Health and Peter Knight, Deputy Director, Head of Research Information and Intelligence, Department of Health Location: Room 8, Palace of Westminster

Sir Harpal Kumar, Cancer Research UK's chief executive, said: «These results could transform the treatment of prostate cCancer Research UK's chief executive, said: «These results could transform the treatment of prostate cancercancer.

Allison, chair of the immunology department at the University of Texas M.D. Anderson Cancer Center in Houston and executive director of its research center on immunotherapy, spoke with Scientific American about the future prospects and limitations of immunotherapy.

«While the presence of lymphocytes in tumors is often associated with better clinical outcomes, this research adds clarity on the diversity of T cells within the tumor environment and their influence on ovarian cancer outcomes,» says first author Kunle Odunsi, MD, PhD, FRCOG, FACOG, Deputy Director, M. Steven Piver Professor and Chair of Gynecologic Oncology, and Executive Director of the Center for Immunotherapy at Roswell Park.

Von Eschenbach, head of prostate cancer research and later executive vice president at M. D. Anderson, later recalled that he felt both «exhilaration» and «almost... terror» when he first flew into D.C..

In his day job, at the University of Texas MD Anderson Cancer Center in Houston, Allison serves as chair of the immunology department, deputy director of the David H. Koch Center for Applied Research of Genitourinary Cancers and executive director of the immunotherapy division of the Moon Shots Program, a multidisciplinary effort tackling cancer mortCancer Center in Houston, Allison serves as chair of the immunology department, deputy director of the David H. Koch Center for Applied Research of Genitourinary Cancers and executive director of the immunotherapy division of the Moon Shots Program, a multidisciplinary effort tackling cancer mortcancer mortality.

«That's not our function,» says Norman Barrett, chief executive of the Association for International Cancer Research.

Obama, he said, elevated the role of science and technology advisers throughout the executive branch, put in place plans to mitigate and prepare the United States for the impacts of climate change, set up health research initiatives to tackle such priorities as cancer and brain research, worked with international partners on scientific issues and used the White House as a platform from which to herald science and education, particularly for children.

Alfred Gilman, the chief scientific officer of the Cancer Prevention and Research Institute of Texas (CPRIT), yesterday wrote to CPRIT Executive Director William Gimson to say that he plans to resign effective 12 October.

«This is an important demonstration of the possibilities opened up for immunotherapy by DMAb technology to direct in vivo production of antibodies of major relevance to human cancer,» said David B. Weiner, Ph.D., executive vice president of The Wistar Institute, director of The Wistar Institute Vaccine & Immunotherapy Center, W.W. Smith Charitable Trust Professor in Cancer Research, and senior author of the cancer,» said David B. Weiner, Ph.D., executive vice president of The Wistar Institute, director of The Wistar Institute Vaccine & Immunotherapy Center, W.W. Smith Charitable Trust Professor in Cancer Research, and senior author of the Cancer Research, and senior author of the study.

The work has important implications for certain types of cancer, says Arthur Gertzman, executive vice-president for research and development at the Musculoskeletal Transplant Foundation in Edison, New Jersey.

Professor Paul Workman, Deputy Chief Executive of The Institute of Cancer Research, London, said: «This work sheds light on the important role of microRNAs in bowel cancer and opens up a potentially exciting new avenue for cancer treaCancer Research, London, said: «This work sheds light on the important role of microRNAs in bowel cancer and opens up a potentially exciting new avenue for cancer treacancer and opens up a potentially exciting new avenue for cancer treacancer treatment.

It was based on the research of Jim Allison, Ph.D., chair of Immunology, executive director of the immunotherapy platform and director of the Parker Institute for Cancer Immunotherapy at MD Anderson.

Dr. Lee Hartwell, president and director, and Dr. Eric Larson, executive directive of Group Health Center of Health Studies (CHS), signed an affiliation agreement on Dec. 19, 2006 — a step that formalizes a long - standing partnership in cancer research.

Pedro de Noronha Pissarra, chief executive officer of Biotecnol said: «We're very proud to work with Cancer Research UK on the development of advanced clinical trial approaches in this competitive and highly promising field of immuno - oncology.

Dr. Kunle Odunsi is the deputy director of the Roswell Park Cancer Institute, where he also serves as the chair of the Department of Gynecologic Oncology, the executive director of the Center for Immunotherapy, and the co-Leader of the Tumor Immunology and Immunotherapy research program.

Dr Peter Sneddon, Cancer Research UK's executive director of clinical and translational research funding, said: «We are delighted that Professor Ashworth has won this well deserveResearch UK's executive director of clinical and translational research funding, said: «We are delighted that Professor Ashworth has won this well deserveresearch funding, said: «We are delighted that Professor Ashworth has won this well deserved award.

David B. Weiner, Ph.D., executive vice president, director of the Vaccine & Immunotherapy Center, and the W.W. Smith Endowed Chair in Cancer Research at The Wistar Institute, and peers received the 2018 Top Ten Clinical Research Achievement Award last night at the National Press Club in Washington, D.C.

«As the largest funder of fibrolamellar research, we are committed to exploring all appropriate research approaches to find a cure — sooner than later,» said John Hopper, executive director of the Fibrolamellar Cancer Foundation.

Executive Director, Silent Spring Institute Website Julia Brody is the Executive Director of Silent Spring Institute, the only scientific research organization dedicated to advancing breast cancer prevention.

On August 1, 2007 she will succeed Lilian Clark, Ph.D., M.B.A. who is leaving CSHL to return to the U.K. to serve as Executive Director of Science Operations and Funding at Cancer Research U.K.. Under Clark's leadership, the Watson School has firmly established its international standing as a premier graduate school.

Last year, he became executive director of the Inland Northwest Cancer Research Consortium in Spokane, which is an alliance of two major health provider corporations in the region — Empire Health Services and Providence Services of Eastern Washington — and WSU.

Trish May, a former Microsoft marketing executive and cancer research philanthropist, will visit Washington State University to make a presentation titled «The Power of One: How Each of Us Can Make a Difference» on March 30.

«The awarding of this second National Cancer Institute multimillion dollar R01 research grant from NIH to Dr. Kelly is indicative of the high esteem in which the breast cancer research community holds her and her work,» said Michael Friedlander, executive director of the VTCRI and Virginia Tech's vice president for health sciences and technCancer Institute multimillion dollar R01 research grant from NIH to Dr. Kelly is indicative of the high esteem in which the breast cancer research community holds her and her work,» said Michael Friedlander, executive director of the VTCRI and Virginia Tech's vice president for health sciences and techncancer research community holds her and her work,» said Michael Friedlander, executive director of the VTCRI and Virginia Tech's vice president for health sciences and technology.

Other senior authors are Charles Keller, MD, who was at Oregon Health & Science University when the research was conducted and is now scientific director and interim executive director of the Children's Cancer Therapy Development Institute in Fort Collins, Colorado; Jacques Grill, MD, PhD, at University of Paris - Sud; and Ranadip Pal, PhD, associate professor of electrical and computer engineering at Texas Tech University.

Weiner joined The Wistar Institute as the Executive Vice President, Director of the Vaccine & Immunotherapy Center, and W.W. Smith Charitable Trust Professor in Cancer Research in 2016.

The Wistar Institute was awarded a $ 1,494,972 grant by the Bill & Melinda Gates Foundation to advance a DNA - based vaccine candidate for protection against malarial infection utilizing a synthetic DNA platform created in the lab of David B. Weiner, Ph.D., executive vice president, director of the Vaccine & Immunotherapy Center at The Wistar Institute and the W.W. Smith Charitable Trust Professor in Cancer Research.

«The approval of a vaccine to treat cancer is a victory in the history of cancer therapy, and signals the beginning of a new era in cancer medicine,» said Jill O'Donnell - Tormey, Ph.D., executive director of the U.S. - based Cancer Research Institute (CRI), a nonprofit organization founded in 1953 that has provided decades of significant support to cancer immunology researchers around the world so that the development of cancer immunotherapies such as Dendreon's Provenge might one day be poscancer is a victory in the history of cancer therapy, and signals the beginning of a new era in cancer medicine,» said Jill O'Donnell - Tormey, Ph.D., executive director of the U.S. - based Cancer Research Institute (CRI), a nonprofit organization founded in 1953 that has provided decades of significant support to cancer immunology researchers around the world so that the development of cancer immunotherapies such as Dendreon's Provenge might one day be poscancer therapy, and signals the beginning of a new era in cancer medicine,» said Jill O'Donnell - Tormey, Ph.D., executive director of the U.S. - based Cancer Research Institute (CRI), a nonprofit organization founded in 1953 that has provided decades of significant support to cancer immunology researchers around the world so that the development of cancer immunotherapies such as Dendreon's Provenge might one day be poscancer medicine,» said Jill O'Donnell - Tormey, Ph.D., executive director of the U.S. - based Cancer Research Institute (CRI), a nonprofit organization founded in 1953 that has provided decades of significant support to cancer immunology researchers around the world so that the development of cancer immunotherapies such as Dendreon's Provenge might one day be posCancer Research Institute (CRI), a nonprofit organization founded in 1953 that has provided decades of significant support to cancer immunology researchers around the world so that the development of cancer immunotherapies such as Dendreon's Provenge might one day be poscancer immunology researchers around the world so that the development of cancer immunotherapies such as Dendreon's Provenge might one day be poscancer immunotherapies such as Dendreon's Provenge might one day be possible.

«The approval of ipilimumab to treat advanced metastatic melanoma is a game changer not only for the thousands of people fighting this disease, but also for the entire field of oncology,» says Jill O'Donnell - Tormey, Ph.D., executive director of the Cancer Research Institute (CRI), a nonprofit organization that since 1953 has worked to advance the science of tumor immunology.

In addition to supporting administrative and executive leadership functions, the Core Grant supports Shared Resources and provides developmental funds to facilitate the cancer - related interdisciplinary research of Cancer Center sciencancer - related interdisciplinary research of Cancer Center scienCancer Center scientists.

The discussion was moderated by Julie Bach, Founder, Wellness for Cancer, Dr. Brent Bauer, MD, Director of Research Integrative Medicine, Mayo Clinic, and Dr. Lisa Corbin, MD, Director of Executive Health Services, Former Director of Integrative Medicine, University of Colorado.

Adriana Azuara, CEO, All4Spas Julie Bach, Executive Director & Founder, Wellness for Cancer Dr. Brent Bauer, Director of Research Integrative Medicine, Mayo Clinic Dr. Lisa Corbin, Director of Executive Health Services, Former Director of Integrative Medicine, University of Colorado David Erlich, Corporate Director of Spa, Sandals Resorts International Susie Ellis, Chairman & CEO, Global Wellness Institute, Global Wellness Summit Martin Goldman, Managing Director, A-spa Maria Fernanda Gomez Hernandez, JD, CEO, Lazz Non Profit Dr. Paola Gomez Hernandez, Director of Integrative Medicine and Quality of Life Program, Lass Non Profit, Hospital Angeles Clinica Londres Dr. Joel Kahn, Chief Medical Officer, eMindful Andrea Leonard, CEO, the Cancer Exercise Specialist Dr. Stephen Lipp, Medical Aesthetics, Biologique Recherché Sherri Maher, Director of Spa Development, Cannaisseur Brands Tom Monrad, Business Development, Health, Corporate and Performance, Technogym USA Rupert Schmid, Co-Chairman, Biologique Recherché Aryn Sieber, CEO & Founder, Cannaisseur Brands Dr Mariela Silveira, Medical Director, Kurotel Longevity Center Zex Suissa, Chief Innovation Officer and Strategic Partnerships, eMindful

The Canine Cancer Genome Project will help to fill a resource gap in cancer research for our beloved family members, people and pets, that are battling the disease,» said Barbara Cohen, Executive Director of Animal Cancer FoundCancer Genome Project will help to fill a resource gap in cancer research for our beloved family members, people and pets, that are battling the disease,» said Barbara Cohen, Executive Director of Animal Cancer Foundcancer research for our beloved family members, people and pets, that are battling the disease,» said Barbara Cohen, Executive Director of Animal Cancer FoundCancer Foundation.